Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2014, vol. 23, nr 6, November-December, p. 901–906

Publication type: original article

Language: English

Association Analysis of the Functional MAOA Gene Promoter and MAOB Gene Intron 13 Polymorphisms in Tension Type Headache Patients

Tuba G. Edgnülü1,A,C,D,E, Aynur Özge2,A,B, Nurten Erdal3,A,E, Oktay Kuru1,D,E, Mehmet E. Erdal4,A,D,E

1 Muğla School of Health Sciences, Muğla Sıtkı Koçman University, Muğla, Turkey

2 Department of Neurology, Faculty of Medicine, Mersin University, Mersin, Turkey

3 Department of Biophysics, Faculty of Medicine, Mersin University, Mersin, Turkey

4 Department of Medical Biology and Genetics, Faculty of Medicine, Mersin University, Mersin, Turkey

Abstract

Background. Monoamine oxidase (MAO) enzymes play an important role in the etiology of many neurological diseases. Tension type headache (TTH) treatments contain inhibitors for selective re-uptake of serotonin and monoamine oxidase inhibitors. MAO (EC 1.4.3.4) has two isoenzymes known as MAOA and MAOB. A promoter polymorphism of a variable number of tandem repeats (VNTR) in the MAOA gene seems to affect MAOA transcriptional activity in vitro. Also, G/A polymorphism in intron 13 (rs1799836) of the MAOB gene have been previously found to be associated with the variability of MAOB enzyme activity.
Objectives. The aim of our study was to investigate a possible association of monoamine oxidase (MAOA and MAOB) gene polymorphisms in tension type headache.
Material and Methods. MAO gene polymorphisms were examined in a group of 120 TTH patients and in another 168 unrelated healthy volunteers (control group). MAOA promoter and MAOB intron 13 polymorphisms were genotyped using PCR-based methods.
Results. An overall comparison between the genotype of MAOA and MAOB genes and allele frequencies of the patients and the control group did not reveal any statistically significant difference between the patients and the control group (p = 0.162).
Conclusion. Factors like estrogen dosage, the limited number of male patients and other genes’ neurotransmitters involved in the etiology of TTH could be responsible for our non-significant results.

Key words

MAOA, MAOB, TTH, PCR-RFLP.

References (26)

  1. Headache Classification Committee of the International Headache Society. The international classification of headache disorders: 2nd ed. Cephalalgia 2004, 24, Suppl 1, 1–160.
  2. Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton RB, Scher AI, Steiner TJ, Zwart JA: The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007, 27, 193–210.
  3. Sabol SZ, Hu S, Hamer D: A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998, 103, 273–279.
  4. Shih JC, Thompson RF: Monoamine oxidase in neuropsychiatry and behaviour. Am J Hum Genet 1999, 65, 593–595.
  5. Chen K, Holschneider D P, Wu W, Rebrin I, Shih JC: A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior. J Biol Chem 2004, 279, 39645–39652.
  6. Balciuniene J, Emilsson L, Oreland L, Pettersson U, Jazin E: Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Hum Genet 2002, 110, 1–7.
  7. Orru S, Mascia V, Casula M, Giuressi E, Loizedda A, Carcassi C, Giagheddu M, Contu L: Association of monoamine oxidase B alleles with age at onset in amyotrophic lateral sclerosis. Neuromuscul Disord 1999, 9, 593–597.
  8. Checkoway H, Franklin GM, Costa-Mallen P, Smith-Weller T, Dilley J, Swanson PD, Costa L: A genetic polymorphism of MAOB modifies the association of cigarette smoking and Parkinson’s disease. Neurology 1998, 50, 1458–1461.
  9. Costa P, Checkoway H, Levy D, Smith-Weller T, Franklin GM, Swanson PD, Costa LG: Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease. Am J Med Genet 1997, 74, 154–158.
  10. Wu RM, Cheng CV, Chen KH, Lu SL, Shan DE, Ho YF, Chern H: The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese. Neurology 2001, 56, 375–382.
  11. Yirmiya N, Pilowsky T, Tidhar S, Nemanov L, Altmark L, Ebstein RP: Family-based and population study of a functional promoter-region monoamine oxidase A polymorphism in autism: possible association with IQ. Am J Med Genet 2002, 114, 284–287.
  12. Wang TJ, Huang SY, Lin WW, Lo HY, Wu PL, Wang YS, Wu YS, Ko HC, Shih JC, Lu RB: Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan. Prog Neuropsychopharmacol Biol Psychiatry 2006, 26, 1–7.
  13. Kunugi H, Ishida S, Kato T, Tatsumi M, Sakai T, Hattori M, Hirose T, Nanko S: A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorder. Mol Psychiatry 1999, 4, 393–395.
  14. Jorm AF, Henderson AS, Jacomb PA, Christensen H, Korten AE, Rodgers B, Tan X, Easteal S: Association of a functional polymorphism of the monoamine oxidase A gene promoter with personality and psychiatric symptoms. Psychiatr Genet 2000, 2, 87–90.
  15. Garpenstrand H, Ekblom J, Forslund K, Rylander G, Oreland L: Platelet monoamine oxidase activity is related to MAOB intron 13 genotype. J Neural Transm 2000, 107, 523–530.
  16. Sery O, Hrazdilova O, Didden W, Klenerová V, Staif R, Znojil V, Sevcík P: The association of monoamine oxidase B functional polymorphism with postoperative pain intensity. Neuro Endocrinol Lett 2006, 3, 29–27.
  17. Miller SA, Dykes, DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16, 1215.
  18. Schulze T, Muller DJ, Krauss H, Scherk H, Ohlraun S, Syagailo YV, Windemuth C, Neidt H, Grässle M, Papassotiropoulos A, Heun R, Nöthen MM, Maier W, Lesch KP, Rietschel M: Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet 2000, 96, 801–803.
  19. Takehashi M, Tanaka S, Masliah E, Ueda K: Association of Monoamine oxidase A gene polymorphism with Alzheimer’s disease and Lewy body variant. Neurosci Lett 2002, 327, 79–82.
  20. Sjöberg RL, Nilsson KW, Wargelius HL, Leppert J, Lindström L, Oreland L: Adolescent girls and criminal activity: role of MAOA-LPR genotype and psychosocial factors. Am J Med Genet B Neuropsychiatr Genet 2007, 5, 159–164.
  21. Gilad Y, Rosenberg S, Przeworski M, Lancet D, Skorecki K: Evidence for positive selection and population structure at the human MAOA gene. Proc Natl Acad Sci USA 2002, 99, 862–867.
  22. Filic V, Vladic A, Stefulj J, Cicin-Sain L, Balija M, Sucic Z, Jernej B: Monoamine oxidases A and B gene polymorphisms in migraine patients. J Neurol Sci 2005, 228, 149–153.
  23. Kelada SN, Costa–Mallen P, Costa LG Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT Jr, Checkoway H: Gender difference in the interaction of smoking genotype in Parkinsons’ disease. Neurotoxicology 2002, 23, 515–519.
  24. Lung FW, Tzeng DS, Huang MF, Lee MB: Association of the MAOA promoter uVNTR polymorphism with suicide attempts in patients with major depressive disorder. BMC Med Genet 2011, 12, 74.
  25. Ishii M, Shimizu S, Sakairi Y, Nagamine A, Naito Y, Hosaka Y, Naito Y, Kurihara T, Onaya T, Oyamada H, Imagawa A, Shida K, Takahashi J, Oguchi K, Masuda Y, Hara H, Usami S, Kiuchi Y: MAOA, MTHFR, and TNF-β genes polymorphisms and personality traits in the pathogenesis of migraine. Mol Cell Biochem 2012, 363, 357–366.
  26. Cevoli S, Mochi M, Scapoli C, Marzocchi N, Pierangeli G, Pini LA, Cortelli P, Montagna P: A Genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol 2006, 3, 1009–1013.
© Wroclaw Medical University